Literature DB >> 9696375

New cytotoxic drugs for intrathecal administration.

S M Blaney1, D G Poplack.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9696375     DOI： 10.1023/a:1005944622003

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  10 in total

1.  Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies.

Authors:  S L Berg; F M Balis; S Zimm; R F Murphy; J Holcenberg; J Sato; G Reaman; P Steinherz; A Gillespie; K Doherty
Journal:  J Clin Oncol       Date:  1992-01       Impact factor: 44.544

2.  High-performance liquid chromatographic analysis of the new antitumour drug SK&F 104864-A (NSC 609699) in plasma.

Authors:  J H Beijnen; B R Smith; W J Keijer; R van Gijn; W W ten Bokkel Huinink; L T Vlasveld; S Rodenhuis; W J Underberg
Journal:  J Pharm Biomed Anal       Date:  1990       Impact factor: 3.935

3.  A rhesus monkey model for continuous infusion of drugs into cerebrospinal fluid.

Authors:  C L McCully; F M Balis; J Bacher; J Phillips; D G Poplack
Journal:  Lab Anim Sci       Date:  1990-09

4.  Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity.

Authors:  R P Hertzberg; M J Caranfa; K G Holden; D R Jakas; G Gallagher; M R Mattern; S M Mong; J O Bartus; R K Johnson; W D Kingsbury
Journal:  J Med Chem       Date:  1989-03       Impact factor: 7.446

5.  Cellular pharmacology in murine and human leukemic cell lines of diaziquone (NSC 182986).

Authors:  M J Egorin; B M Fox; J F Spiegel; P L Gutierrez; R D Friedman; N R Bachur
Journal:  Cancer Res       Date:  1985-03       Impact factor: 12.701

6.  Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone.

Authors:  S Zimm; J M Collins; G A Curt; D O'Neill; D G Poplack
Journal:  Cancer Res       Date:  1984-04       Impact factor: 12.701

7.  Phase II and pharmacokinetic study of aziridinylbenzoquinone [2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone, diaziquone, NSC 182986] in high-grade gliomas.

Authors:  G A Curt; J A Kelley; C V Kufta; B H Smith; P L Kornblith; R C Young; J M Collins
Journal:  Cancer Res       Date:  1983-12       Impact factor: 12.701

8.  Intrathecal administration of topotecan in nonhuman primates.

Authors:  S M Blaney; D E Cole; K Godwin; C Sung; D G Poplack; F M Balis
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  Diaziquone, 2,5-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone, plasma and cerebrospinal fluid kinetics.

Authors:  N R Bachur; J M Collins; J A Kelley; D A Van Echo; R S Kaplan; M Whitacre
Journal:  Clin Pharmacol Ther       Date:  1982-05       Impact factor: 6.875

10.  Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates.

Authors:  S M Blaney; D E Cole; F M Balis; K Godwin; D G Poplack
Journal:  Cancer Res       Date:  1993-02-15       Impact factor: 12.701
  10 in total
  13 in total

Review 1.  Intrathecal chemotherapy with antineoplastic agents in children.

Authors:  A Ruggiero; V Conter; M Milani; E Biagi; I Lazzareschi; P Sparano; R Riccardi
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Embryonic tumours of the central nervous system.

Authors:  Aurora Navajas Gutiérrez; Ana Fernández-Teijeiro Alvarez
Journal:  Clin Transl Oncol       Date:  2005-06       Impact factor: 3.405

3.  Leptomeningeal Neoplasms.

Authors:  Lauren E. Abrey
Journal:  Curr Treat Options Neurol       Date:  2002-03       Impact factor: 3.598

4.  Neoplastic meningitis resulting from hematological malignancies: pharmacokinetic considerations and maximizing outcome.

Authors:  Jai Grewal; Marlon Saria; Harpreet K Grewal; Santosh Kesari
Journal:  Clin Investig (Lond)       Date:  2011-10

5.  Intrathecal chemotherapy with MX2 for treating glioma dissemination in vivo.

Authors:  S Mizumatsu; K Matsumoto; Y Ono; T Tamiya; T Furuta; T Ohmoto
Journal:  J Neurooncol       Date:  2000-08       Impact factor: 4.130

Review 6.  Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis.

Authors:  Gudrun Fleischhack; Ulrich Jaehde; Udo Bode
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 7.  Neoplastic meningitis: diagnosis and treatment considerations.

Authors:  S M Blaney; D G Poplack
Journal:  Med Oncol       Date:  2000-08       Impact factor: 3.064

Review 8.  Neoplastic meningitis.

Authors:  Ana Aparicio; Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

Review 9.  Neoplastic meningitis.

Authors:  Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2008-05       Impact factor: 5.081

10.  Synergy of karenitecin and mafosfamide in pediatric leukemia, medulloblastoma, and neuroblastoma cell lines.

Authors:  Eufemia Jacob; Kathy Scorsone; Susan M Blaney; David Z D'Argenio; Stacey L Berg
Journal:  Pediatr Blood Cancer       Date:  2008-04       Impact factor: 3.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.